1GMC

THE X-RAY CRYSTAL STRUCTURE OF THE TETRAHEDRAL INTERMEDIATE OF GAMMA-CHYMOTRYPSIN IN HEXANE

Structural Biology Knowledgebase: 1GMC SBKB.org


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.2 Å
  • R-Value Observed: 0.176

Literature

Macromolecules
Sequence Display for 1GMC

Classification: HYDROLASE

Total Structure Weight: 25669.19

Macromolecule Entities
Molecule Chains Length Organism Details
GAMMA-CHYMOTRYPSIN A E 13 Bos taurus EC#: 3.4.21.1 IUBMB
Gene Name(s):
Metabolic Pathways
Maps:       
Reactions:
ESCHER  BiGG
GAMMA-CHYMOTRYPSIN A F 131 Bos taurus EC#: 3.4.21.1 IUBMB
Gene Name(s):
GAMMA-CHYMOTRYPSIN A G 97 Bos taurus EC#: 3.4.21.1 IUBMB
Gene Name(s):
PRO GLY ALA TYR PEPTIDE B 4 synthetic


Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.2 Å
  • R-Value Observed: 0.176
  • Space Group: P 42 21 2

Unit Cell:

Length (Å) Angle (°)
a = 69.54 α = 90.00
b = 69.52 β = 90.00
c = 98.01 γ = 90.00

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History

Deposition Data

  • Deposited Date: 1993-08-20
  • Released Date: 1993-10-31
  • Deposition author(s): Yennawar, N.H., Yennawar, H.P., Banerjee, S., Farber, G.K.

Revision History

  • 2013-03-13
    Type: Other | Details: Remove PRD info on PRD molecule with WAIT status
  • 2012-12-12
    Type: Other | Details: Add PRD info
  • 2011-07-13
    Type: Version format compliance | Details: compliance with PDB Exchange Dictionary V4
  • 2011-07-13
    Type: Atom nomenclature | Details: Atom nomenclature
  • 2011-07-13
    Type: Binding sites and description | Details: Binding sites and description
  • 2011-07-13
    Type: Non-polymer description | Details: Non-polymer description
  • 2011-07-13
    Type: Function and keywords | Details: Function and keywords
  • 2011-07-13
    Type: Linkage | Details: Linkage
  • 2011-07-13
    Type: Sequence database correspondence | Details: Sequence database correspondence
  • 2011-07-13
    Type: Polymer description | Details: Changed inhibitor presentation or chemistry